The Influence of Extracorporeal Membrane Oxygenation on Antibiotic Pharmacokinetics
Extracorporeal membrane oxygenation (ECMO) is becoming increasingly utilized to support critically ill patients who experience life-threatening cardiac or pulmonary compromise. The provision of this intervention poses challenges related to its complications and the optimization of medication therapy...
Main Authors: | Gregory J. Peitz, Daryl J. Murry |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2023-03-01
|
Series: | Antibiotics |
Subjects: | |
Online Access: | https://www.mdpi.com/2079-6382/12/3/500 |
Similar Items
-
Population Pharmacokinetics of Vancomycin and Meropenem in Pediatric Extracorporeal Membrane Oxygenation Support
by: Brenda Zylbersztajn, et al.
Published: (2021-08-01) -
Population Pharmacokinetics of Amikacin in Patients on Veno-Arterial Extracorporeal Membrane Oxygenation
by: Claire Pressiat, et al.
Published: (2022-01-01) -
Medication and Dose Optimization in Extracorporeal Membrane Oxygenation
by: Nadir Yalçın, et al.
Published: (2024-03-01) -
Population Pharmacokinetics and Dosing Optimization of Piperacillin-Tazobactam in Critically Ill Patients on Extracorporeal Membrane Oxygenation and the Influence of Concomitant Renal Replacement Therapy
by: Jongsung Hahn, et al.
Published: (2021-12-01) -
ASAP ECMO: Antibiotic, Sedative and Analgesic Pharmacokinetics during Extracorporeal Membrane Oxygenation: a multi-centre study to optimise drug therapy during ECMO
by: Shekar Kiran, et al.
Published: (2012-11-01)